Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial.
De Jaeghere EA, Hamerlinck H, Tuyaerts S, Lippens L, Van Nuffel AMT, Baiden-Amissah R, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Verhasselt B, Denys HG.
De Jaeghere EA, et al. Among authors: van dam pa.
Gynecol Oncol. 2024 Nov 7;191:275-286. doi: 10.1016/j.ygyno.2024.10.020. Online ahead of print.
Gynecol Oncol. 2024.
PMID: 39515198